West Nile virus (WNV) (Flavivirus: Flaviviridae) is the most widespread arbovirus in the world. A significant range expansion occurred beginning in 1999 when the virus was introduced into New York City. This review highlights recent research into WNV epizootiology and epidemiology, including recent advances in understanding of the host-virus interaction at the molecular, organismal, and ecological levels. Vector control strategies, vaccines, and antivirals, which now must be considered on a global scale, are also discussed. 
WNV: West Nile virus
a host-derived lipid bilayer bearing dimers of the viral envelope protein and the membrane protein. Thus, the antigenic, genetic, and three-dimensional structure of WNV and its constituent proteins are similar to several other flaviviruses and form the basis for its classification (91) .
Host Response to Infection
Host cells possess a wide array of antiviral mechanisms that interfere with virus replication (see References 16, 17, 21, and 146). Elucidating these mechanisms and understanding how WNV subverts them are areas of intense research because the findings may lead to a better understanding of pathogenesis and consequently the development of novel interventions. Arboviruses, including WNV, are of particular interest because they rely on taxonomically diverse hosts (e.g., mosquitoes and birds) for perpetuation in nature. These hosts differ markedly in their response to WNV infection. Ongoing research is leading to a clearer understanding of the mechanisms for the invertebrate innate response to infection, and it is hoped that they will someday be manipulated to influence arbovirus transmission dynamics. The best-characterized innate antiviral mechanisms in arthropods and arthropod cells are RNA interference pathways. These pathways are active in several mosquito species (98, 121) and can be manipulated to render mosquitoes less susceptible to arbovirus infection (40, 60). Although no published work yet addresses the WNV system using relevant mosquitoes (i.e., Culex) or their cells as hosts, much of the existing literature derived from other mosquito species should be applicable to the WNV-mosquito interaction. Sequencing of the Culex quinquefasciatus genome (VectorBase) will allow these studies to proceed rapidly.
EPIDEMIOLOGY AND ECOLOGY

Geographic Distribution and Outbreaks
WNV is currently the most widely distributed arbovirus in the world, occurring on all continents except Antarctica. The virus was first isolated from a febrile woman in Uganda in 1937 (129) and subsequently was associated with sporadic cases of disease as well as major outbreaks in Africa, Eurasia, Australia, and the Middle East. Serosurveys of humans and equines and entomological studies during the 1950s in Egypt and the upper Nile delta (124, 137) Table 1 ]. In 1999, recognition of human cases was presaged by weeks by reports of dead exotic and domestic birds in the New York City area (134). WN disease also has been noted in humans in Cuba (107) and the Cayman Islands (67) and in equines in Argentina (87) , but scant evidence of human and equine morbidity and mortality has been observed in tropical America, possibly because of cross-protection from other 
Molecular Epidemiology
In recent years substantial effort has been devoted to understanding the molecular epidemiology of WNV in order to provide a more detailed understanding of virus spread, population dynamics, viral determinants of pathogenesis, and mosquito trans- (144, 149) . WNV populations are dominated by strong purifying selection, with nonsynonymous substitutions rapidly removed from sequences relative to synonymous substitutions (54). Finally, WNV populations appear to be structured as quasispecies in nature, with infection of mosquitoes leading to greater genetic diversity than bird infection and to some amount of genetic diversity shared between hosts (54, 55).
TRANSMISSION CYCLE Enzootic Cycle
Throughout its worldwide distribution, WNV is maintained in nature in an enzootic cycle between ornithophilic mosquitoes, predominantly Culex (Culex) species, and birds. Approximately 59 species of mosquitoes and 284 species of birds (48) have been found infected in North America. Therefore, WNV is apparently an ecological generalist compared to other arboviruses that are more limited in the range of vectors and vertebrates that they infect. This generalization has likely contributed to the broad geographic distribution of the virus and the human and animal disease it causes (Figure 3) .
Several important questions remain to be answered regarding the dynamics of the WNV transmission cycle. First, the importance of corvids in the amplification cycle is unresolved. Human cases have been associated with clusters of dead American crows in California (112) and New York (33), but blood meal analyses of engorged mosquitoes do not indicate strong evidence of feeding on crows; instead other birds seem to be more important hosts (5, 61). Second, it remains unclear why the high avian mortality observed in the United States has rarely been observed either in the Old World or in tropical America. Possible explanations include those discussed above and differences in avian populations such as historical exposure of the birds to WNV or related flaviviruses. Whatever the underlying causes of the increased avian mortality from WNV in the United States, it likely increases the intensity of transmission (i.e., R o ) in the enzootic cycle partly by removing individuals who would have become immune. This increase in enzootic R o might be expected to result in more human infections. Third, conventional wisdom suggests that only birds contribute to enzootic perpetuation of WNV. Evidence is accumulating that some mammals and reptiles may in fact be competent amplification hosts for WNV. Squirrels, for example, mount viremias sufficiently high to infect at least a low proportion of mosquitoes (116). Alligators farmed under conditions of high temperatures in a crowded environment demonstrated significant morbidity (53) and mortality (84) , and following experimental infection they demonstrated high levels of viremia, >10 5 pfu ml −1 , that could infect C. quinquefasciatus Say 1823 (65) . However, the virus may have been transmitted directly between animals under these crowded conditions via cloacal shedding. Finally, the importance of the experimental observation of cofeeding transmission, wherein a low proportion of uninfected mosquitoes becomes infected following feeding in temporal and spatial proximity to infected mosquitoes, is unknown in nature (82, 114) . Additional studies are required to understand whether the generalist nature of the vector and vertebrate host ranges that seems to be a hallmark of WNV infection is indeed critical for its perpetuation.
Bridge Vectors and Alternative Transmission Mechanisms
Bridge vectors (distinct from enzootic vector species) are typically involved for significant numbers of humans to become infected with zoonotic arboviruses such as WNV. Several recent observations, however, have challenged this view. Population density and host feeding studies (63, 64) showing a strong temporal association between shifts in C. pipiens feeding behavior from a strong to a weak focus on American robins and an increase in human cases (64 The role of nonmosquito vectors in WNV epizootiology continues to be explored. Experimental transmission has been demonstrated with soft ticks (1, 51), but not with ixodid ticks (75) . WNV has been isolated from soft (argasid) ticks in Israel (92) and hippoboscid flies in the United States (37). Owing to the relative infrequency of these isolations and robust WNV-mosquito interactions, these other arthropod vectors seem unlikely to play a critical role. There also is strong evidence for nonvector routes of transmission, as with bird-to-bird transmission through the fecal-oral route and through consumption of infected carrion (68) . Humans have become infected through blood transfusion, organ transplantation, and other novel routes (70) .
Other Factors
Intrinsic factors influence the epidemiology of WNV. Detailed experiments have established that vertebrates vary in their morbidity, mortality, and host competence (68, 95, 115) and that mosquito species differ in vector competence (42, 122, 142) 74) . Other intrinsic factors that may influence WNV epidemiology in a more powerful way include mosquito feeding behavior and longevity (135), which are extensively reviewed elsewhere (69) . Extrinsic factors such as temperature and rainfall patterns (35) and the density of susceptible host populations are also important in determining the intensity of WNV transmission (69) . An integrated understanding of how extrinsic and intrinsic factors interweave to produce WNV epidemics requires further field-and laboratory-based studies. Such an understanding is a prerequisite for developing rational control strategies.
LONG-TERM PERPETUATION AND SPREAD
Re-introduction
Circulation of WNV in Europe and Africa occurred sporadically with limited outbreaks until activity began to increase in 1996, particularly in the Mediterranean basin, as has been reviewed thoroughly in other papers (24, 150). For example, the virus reappeared in southeastern France, in the Camargue district, in 2000 after 35 years with no evidence of overt activity and low seroprevalence in humans and equines (6, 24, 93) . Western Mediterranean wetlands such as the Camargue attract birds from central Asia, Siberia, northern and eastern Europe, western Africa, and the Mediterranean basin, and numerous birds of various species are seasonally aggregated in these habitats (56). Migratory birds are important in spreading virus, as with the introduction of WNV into Israel (79) leading to multiple genotypes circulating concurrently, and into Slovakia (36). Birds also have been proposed to be the agents of long-distance movement of WNV in the Western Hemisphere (101, 109) , while mosquitoes and dispersing birds may move the virus locally (108) . A better understanding of avian migratory routes is needed to verify models and simulations of viral movement; however, it is probable that they play a critical role in determining the dynamics of the spread of this virus. An alternative mechanism of virus spread is through dispersal from an endemic area via migrant infected mosquitoes. This mechanism of virus spread has been reviewed thoroughly (69) .
Maintenance within an Enzootic Focus
There are several potential mechanisms of WNV perpetuation within an enzootic focus in habitats conducive to virus transmission where mosquitoes and birds live closely together. They include low-level continuous enzootic transmission, vertical transmission by mosquito vector(s), and chronic infection in birds. From 2000 to 2004 in the Camargue, most likely owing to local perpetuation, equine epizootics occurred accompanied by human cases and sentinel bird seroconversion. WNV has been isolated from field-collected larvae and/or male C. univittatus mosquitoes in Kenya (83) and from larvae (103) or diapausing adults in the United States (3, 94), among others. This discovery has led to the belief that vertical transmission of WNV from parent to progeny plays a significant role in the virus's perpetuation. Flaviviruses appear to enter the fully formed egg through the micropyle at the time of fertilization (117). This is an inefficient mechanism of vertical transmission, yet it does permit the infection of progeny following a single maternal blood meal. Laboratory studies also have successfully demonstrated vertical transmission of WNV by C. tritaeniorhynchus, Aedes albopictus, A. aegypti (9), C. pipiens (143) , and C. tarsalis (43); however, most of these studies used intrathoracic inoculation as the means of infection. It remains unclear whether the low vertical transmission rates observed with WNV are sufficient to allow virus to survive winter in temperate environments. Temperate Culex spp. enter diapause to survive winter conditions without having taken a blood meal (85) ; therefore overwintering adults must beVertical transmission: transmission of virus from a parental female mosquito to its progeny without infection of the germline cells come infected through vertical transmission, and they must survive the winter infected with virus. However, others believe diapausing Culex spp. may host-seek in nature (34) and would therefore survive the winter after potentially having taken an infectious blood meal.
Virus also might perpetuate in an enzootic focus over time through persistent infection in birds, as has been demonstrated experimentally in diverse tissues of various avian species (68, 113) . No studies to date have demonstrated infection of mosquitoes following feeding on vertebrates with persistent infection; however, ingestion of persistently infected carrion by susceptible hosts may present an alternative mode of transmission. The relative importance of persistence of WNV in vertebrates (139) needs further study.
STRATEGIES FOR CONTROL AND TREATMENT
Vector Control
Surveillance efforts have focused on mosquitoes, dead birds, and sentinel chickens. WNV-infected mosquito pools were the most accurate indicator of human cases when mosquito and avian surveillance approaches were compared in one study (18). Significantly higher C. quinquefasciatus infection rates and incidence of human cases were found in proximity to clusters of dead crows in another study (112). Because avian mortality is a passive surveillance tool that depends on public reporting, the effectiveness of this strategy may decrease over time.
Because of the large impact of WNV on human and animal health, it is critical to develop effective methods to limit WNV transmission and prevent and/or treat WN disease. Currently, control measures to curtail WNV transmission include reducing mosquito vector populations and limiting exposure to mosquito bites with protective clothing and repellents. Vector control agencies often use a combination of approaches (mosquito population monitoring, mosquito source reduction, larvicide and adulticide application, and public education) to reduce mosquito populations. In 2002, a program relying on surveillance and larvicide and adulticide applications was implemented in St. Tammany Parish, Louisiana, resulting in reductions in mosquito populations below the five-year average and a subsequent drop in new human WNV cases (99) .
Monitoring the effectiveness of mosquito control programs and targeting control efforts to high-risk areas and peak mosquito activity periods are critical to maximize benefits. Following the Florida hurricanes in 2004, aerial spraying of adulticides reduced the number of mosquitoes caught in CDC-type light traps by 67.7% (128) . On the other hand, there was no difference in Culex abundance at three suburban sites in Massachusetts following a single application of resmethrin from vehiclemounted ultra-low volume generators; this lack of control was not due to insecticide resistance of the target population (111). Hostseeking and oviposition behaviors for Culex mosquitoes in the northeastern United States peaked approximately two hours after sunset; aerial application of insecticides during this time of increased flight activity is likely to improve control outcomes (110). Several GISbased spatial models of WNV transmission have been developed (23, 118, 136). These models use a variety of predictor variables, including temperature, rainfall, vegetation, landscape, and geographic data, to predict locations of high WNV transmission risk. This type of information is useful for targeting mosquito control efforts, locating trapping sites for surveillance, and focusing prevention efforts.
Concerns have been raised regarding the health and environmental effects of pesticides used to control WNV epidemics. After widespread pyrethroid spraying in New York City in 2000, there was no population-level increase in emergency department visits for asthma (59). Risks from WNV infection exceeded risks from exposure to mosquito insecticides when compared using a risk assessment (102) . However, this analysis did not consider the effectiveness of mosquito insecticides at reducing WN disease (i.e., a risk-benefit analysis of insecticide use), and thus the benefits of spraying may be overestimated (125) . After widespread aerial spraying of pyrethrin insecticides around Sacramento, California, for WNV control, water and sediment samples were taken from nearby creeks and tested for insecticide residues and toxicity. No toxicity was detected from the active ingredient, pyrethrin; however, the synergist, piperonyl butoxide, reacted with preexisting pyrethroids in the sediment and caused a twofold increase in toxicity (147) .
Because of increased resistance of mosquito populations to conventional control agents, there have been renewed efforts to develop novel biopesticides. A recombinant bacterial strain expressing the toxins of Bacillus thuringiensis israelensis and B. sphaericus was 20-fold-more toxic than either of the parental strains and less likely to induce resistance in target populations (100) . Mosquito baculoviruses, such as C. nigripalpus nucleopolyhedrovirus, are highly virulent for certain mosquito species and could be developed as biopesticides (11) . Additionally, recent demonstrations of Anopheles mosquito control using entomopathogenic fungi suggest that this technique could be a viable strategy for future control of WNV vectors (57).
New strategies to control mosquito populations have been proposed. Field trials of a mass-trapping strategy that used mosquito traps with a combination of attractants (heat, CO 2 , octenol) demonstrated good levels of mosquito control on islands or when one species is dominant in an area (66) . Masstrapping may become a more viable strategy as knowledge of mosquito attractants improves. Relatively simple strategies, such as using floating layers of polystyrene beads to obstruct the water surface, can result in suffocation of mosquito larvae because they cannot penetrate the water surface to breathe (25). This technique would be useful to control Culex mosquitoes breeding in enclosed spaces, such as flooded basements or cess pits. A novel strategy currently pursued to control malaria and dengue involves the creation of transgenic mosquitoes that are incapable of transmitting pathogens (40, 52). This strategy seems more problematic for control of WNV due to the complexity of the WNV transmission cycle.
Vaccines and Antiviral Treatments
Vaccines can be used to prevent WNV infection and antiviral treatments can be used to treat severe disease (reviewed in Reference 70). There are currently four licensed WNV vaccines for horses and one licensed vaccine for domestic geese ( Table 2) . Although no vaccine has been approved for use in humans, significant progress has been made, with ongoing clinical trials of four vaccines ( Table 2) . Several strategies have been employed to deliver WNV antigens into animals for vaccination purposes. The first is inoculation of multiple doses of inactivated (killed) virus (119) . A second strategy involves expression of WNV viral proteins in a host to elicit an immune response. Viral proteins can be inoculated directly into the host, as a recombinant subunit vaccine (22, 76, 77), or they can be produced by host cells following inoculation of DNA plasmids (26) or virus vectors that express WNV genes (58). The third strategy involves the use of chimeric viruses containing the PrM and E genes of WNV within a heterologous attenuated flavivirus backbone [Yellow fever 17D (86), DEN2 PDK-53 (49) or DEN4-3delta30 (104)]. The final vaccination strategy is based on attenuated viruses. Several types of attenuated viruses have been created by introducing mutations into nonstructural genes (45, 148), resulting in reduced virus replication, or by introducing mutations into the capsid gene (81, 126), disabling the release of virus from the cell.
Currently there is no specific treatment for WNV disease in humans, although several (127); the safety and efficacy of this treatment are being tested in phase I/II clinical trials. Antibody therapy using humanized monoclonal antibodies directed against the WNV envelope protein is therapeutically effective in mice and hamsters. A single dose of these antibodies given to animals at 5 days post-infection (when neurons are infected with WNV) protected animals from WNV-induced mortality and resulted in decreased viral titers in the brain (88, 97) . Interferon therapy effectively controlled WNV infection in vitro and in animal models (4, 120) . A clinical trial is currently underway to test the safety and efficacy of interferon therapy for West Nile meningocephalitis in humans. Oligomers with complementary sequence to portions of the WNV genome (antisense therapies) have shown significant antiviral activity in vitro (29, 140). The safety and efficacy of one antisense compound (AVI-4020) against WNV ND are being tested in a clinical trial. High-throughput assays developed by two groups (44, 105) are being used to screen compounds for antiviral activity. One of these assays identified triaryl pyrazoline as an inhibitor of flavivirus replication in cell culture (106) .
CONCLUSION
WNV serves as a model for zoonotic diseases that are emerging, re-emerging, or expanding their ranges globally. It is critical to conduct research on the underlying biological and geographic factor(s) that allows these pathogens to adapt to new hosts and environments. A better understanding will allow improved prediction of risk and approaches to control.
SUMMARY POINTS
1. WNV is the most widely distributed arbovirus known; the factors explaining this are complex, including vector-virus-host interactions and climatic factors.
WNV is well established in the Western
Hemisphere and activity will most likely continue at levels determined by virus, host, and environmental factors throughout its range.
3. The WNV cycle is complex and details vary by region, making it difficult to model on a broad scale, but the predominant enzootic hosts are Culex mosquitoes and birds.
4. Migratory birds are the most likely mechanism of long-distance virus spread, but mosquitoes and dispersing birds may carry the virus shorter distances.
5. Current control measures against WNV consist of mosquito population reduction and personal protective measures; however, new chemical control agents and new control strategies are being pursued.
6. Several WNV vaccines have been licensed for use in horses; significant progress has been made in the development of WNV vaccines for humans.
7. No specific antiviral treatment exists for WNV, although several candidates are currently being tested in clinical trials.
FUTURE ISSUES
1. Sequencing of the Culex genome will allow more detailed studies of the genetic basis of vector-virus-vertebrate interactions.
2. Molecular epidemiological and fitness studies of WNV strains isolated over space and time will provide information on viral evolution and adaptation.
3. A better understanding of the role of avian migration in long-term perpetuation and spread of virus will increase the ability to predict movement of zoonotic pathogens in the future.
4. Significance of viral persistence in vertebrate hosts is important to our understanding of disease and virus perpetuation.
5. Mathematical models that integrate human infection with mosquito surveillance data should be developed to improve risk prediction.
6. An increased understanding of the impact of climate on spatial and temporal variation in virus activity, and of the drivers of spatial variation in transmission, will improve risk analyses.
7. Integration of structural biology with virology and viral genetics will allow for more detailed understanding of host-virus interactions.
8. Improved diagnostic assays are needed to distinguish among flaviviruses.
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